OVA負(fù)載的3D支架疫苗
| 【Numbering】BKMC100010 | 【CAS】CAS | ||
| 【Item No.】BKMC100010-2 | 【specification】 | ||
|
|||
Name: OVA-loaded 3D stent vaccine
Composition: 3D stent tumor antigen adjuvant
Particle size: micron-scale mesh structure
Applications: Preventive and therapeutic cancer vaccines
Storage conditions: -4℃
Other instructions: Half year shelf life under sealed state [Main advantage] can effectively induce DC maturation; compared with traditional hydrogel, 3D stent with porous structure gives it similar function to real lymphoid organs by raising a large number of immune cells, leading to the formation of "artificial tertiary lymphoid structure", which has promising sites to enhance humoral and cellular immune response.
Title:3D Printing Scaffold Vaccine for Antitumor Immunity
Message
Composition: 3D stent tumor antigen adjuvant
Particle size: micron-scale mesh structure
Applications: Preventive and therapeutic cancer vaccines
Storage conditions: -4℃
Other instructions: Half year shelf life under sealed state [Main advantage] can effectively induce DC maturation; compared with traditional hydrogel, 3D stent with porous structure gives it similar function to real lymphoid organs by raising a large number of immune cells, leading to the formation of "artificial tertiary lymphoid structure", which has promising sites to enhance humoral and cellular immune response.
Title:3D Printing Scaffold Vaccine for Antitumor Immunity
Article link:https://pubmed.ncbi.nlm.nih.gov/34601760/
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
Next： 仿生巨噬細(xì)胞膜載CRISPR/Cas9
